UCB Stock CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 259.45 EUR | 0.00% |
|
0.00% | - |
| 25/06 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 22/06 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
| Market Cap | 49.09B 55.92B 45.19B 42.11B 79.41B 5,316B 81.03B 544B 211B 2,609B 210B 205B 9,082B | P/E 2026 * |
27.8x | P/E 2027 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise Value | 48.82B 55.61B 44.94B 41.88B 78.98B 5,287B 80.58B 541B 209B 2,595B 209B 204B 9,031B | EV / Sales 2026 * |
5.72x | EV / Sales 2027 * | 4.86x |
| Free-Float |
61.59% | Yield 2026 * |
0.57% | Yield 2027 * | 0.58% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 55.92B | |
| +1.18% | +0.21% | +16.79% | -13.06% | 63.56B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.68B | |
| -0.52% | +0.08% | -50.89% | -57.38% | 39.12B | |
| +1.21% | +5.09% | +61.25% | -26.37% | 30.97B | |
| +5.28% | +19.99% | +152.70% | -40.33% | 28.77B | |
| +0.52% | +4.93% | +65.59% | +82.83% | 22.74B | |
| +7.22% | +12.16% | +7.63% | +184.50% | 17.64B | |
| +1.24% | +0.34% | +65.24% | +126.51% | 16.66B | |
| +0.35% | +7.44% | +74.19% | +333.26% | 14.6B | |
| Average | +1.60% | +5.38% | +48.01% | +69.95% | 30.64B | |
| Weighted average by Cap. | +1.17% | +4.55% | +39.21% | +31.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.72B 7.85B 7.32B 13.8B 924B 14.08B 94.47B 36.6B 454B 36.49B 35.7B 1,579B | 9.63B 10.97B 8.87B 8.26B 15.58B 1,043B 15.9B 107B 41.33B 512B 41.2B 40.31B 1,782B |
| Net income | 1.75B 1.99B 1.61B 1.5B 2.83B 189B 2.88B 19.34B 7.5B 92.88B 7.47B 7.31B 323B | 2.26B 2.58B 2.08B 1.94B 3.66B 245B 3.74B 25.06B 9.71B 120B 9.68B 9.47B 419B |
| Net Debt | -271M -309M -250M -233M -439M -29.38B -448M -3B -1.16B -14.42B -1.16B -1.14B -50.18B | -2.31B -2.63B -2.13B -1.98B -3.74B -250B -3.82B -25.61B -9.92B -123B -9.89B -9.68B -428B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
Select your edition
All financial news and data tailored to specific country editions
